| Versant Venture Capital Vi, L.P. |
Non-Executive |
Graphite Bio, Inc. (GRPH)
|
2021-06-29 |
$119.00 |
-81.3% |
25,714
|
$3,060,000 |
| Versant Venture Capital Vi, L.P. |
Non-Executive |
Monte Rosa Therapeutics, Inc. (GLUE)
|
2021-06-28 |
$19.00 |
-68.4% |
157,895
|
$3,000,005 |
| Versant Venture Capital Vi, L.P. |
Non-Executive |
Century Therapeutics, Inc. (IPSC)
|
2021-06-22 |
$20.00 |
-92.8% |
100,000
|
$2,000,000 |
| Versant Venture Capital Vi, L.P. |
Non-Executive |
Aligos Therapeutics, Inc. (ALGS)
|
2020-10-20 |
$375.00 |
-96.8% |
8,000
|
$3,000,000 |
| Versant Venture Capital Vi, L.P. |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2020-03-03 |
$360.00 |
-99.8% |
11,250
|
$4,050,000 |
| Versant Venture Capital Vi, L.P. |
Non-Executive |
Black Diamond Therapeutics, Inc. (BDTX)
|
2020-02-03 |
$19.00 |
-70.6% |
894,736
|
$16,999,984 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-78.9% |
$-25,349,292 |
$32,109,989 |